Patents by Inventor Richard T. Robinson

Richard T. Robinson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200046484
    Abstract: There is disclosed a porous emboli deflector for preventing cerebral emboli while maintaining cerebral blood flow during an endovascular or open surgical procedure. The device prevents the entrance of emboli of a size able to cause stroke (such as greater than 100 microns) from entering either the right or left common carotid arteries, and/or the right or left vertebral arteries by deflecting emboli downstream of these vessels. The device can be placed prior to any manipulation of the heart or aorta allowing maximal protection of the brain during the index procedure. The deflector has a low profile within the aorta which allows sheaths, catheters, or wires used in the index procedure to pass. Also disclosed are methods for insertion and removal of the deflector.
    Type: Application
    Filed: October 1, 2019
    Publication date: February 13, 2020
    Inventors: Judith T. Carpenter, Jeffrey P. Carpenter, David A. Rezac, Jeffrey C. Cerier, Richard C. Fortier, Timothy W. Robinson
  • Patent number: 10453114
    Abstract: Selective/controlled disclosure of user information to private workspaces of other users/invitees based on context/contextual relations, and a shared workspace or market to collaborate amongst the other users (e.g., to crowd-source gifts of interest to the recipient). Contextual disclosure may be based on common context or commonality under a set of conditions, such as a topic, which may include known topics of relationships amongst the users and/or undiscovered contexts. As an example, items of interest to each user are identified and clustered, keywords are assigned to the clusters indicative of topics/subjects of interests to the respective users, recipient keywords are compared to keywords of an invitee to identify common keywords as shared interests, and items of interest to the recipient that relate to the common keywords are disclosed to the invitee as a personalized wish-list. Keyword weighting and/or keyword/item level privacy designations may be provided to further control disclosure.
    Type: Grant
    Filed: June 23, 2014
    Date of Patent: October 22, 2019
    Assignee: Intel Corporation
    Inventors: Rita H Wouhaybi, Timothy G Coppernoll, Jose K Sia, Jr., Richard T Beckwith, Maria Bezaitis, Scott H Robinson, Vinay Phegade, Michael Lemay
  • Patent number: 10426591
    Abstract: There is disclosed a porous emboli deflector for preventing cerebral emboli while maintaining cerebral blood flow during an endovascular or open surgical procedure. The device prevents the entrance of emboli of a size able to cause stroke (such as greater than 100 microns) from entering either the right or left common carotid arteries, and/or the right or left vertebral arteries by deflecting emboli downstream of these vessels. The device can be placed prior to any manipulation of the heart or aorta allowing maximal protection of the brain during the index procedure. The deflector has a low profile within the aorta which allows sheaths, catheters, or wires used in the index procedure to pass. Also disclosed are methods for insertion and removal of the deflector.
    Type: Grant
    Filed: May 12, 2016
    Date of Patent: October 1, 2019
    Assignee: Edwards Lifesciences AG
    Inventors: Judith T. Carpenter, Jeffrey P. Carpenter, David A. Rezac, Jeffrey C. Cerier, Richard C. Fortier, Timothy W. Robinson
  • Patent number: 8877212
    Abstract: The present invention describes compositions for both diagnostic and therapeutic applications. In one embodiment, the present invention contemplates a method of identifying an active M. tuberculosis infection. In another embodiment, the present invention contemplates a method of monitoring a M. tuberculosis infection. In yet another embodiment, the present invention contemplates a method of monitoring a patient's response to treatment for an active M. tuberculosis infection. In a further embodiment, the present invention contemplates a method of monitoring a patient's response to treatment for an active M. tuberculosis infection.
    Type: Grant
    Filed: February 11, 2013
    Date of Patent: November 4, 2014
    Assignee: Trudeau Institute
    Inventors: Richard T. Robinson, Andrea M. Cooper
  • Publication number: 20140227324
    Abstract: The present invention describes compositions for both diagnostic and therapeutic applications. In one embodiment, the present invention contemplates a method of identifying an active M. tuberculosis infection. In another embodiment, the present invention contemplates a method of monitoring a M. tuberculosis infection. In yet another embodiment, the present invention contemplates a method of monitoring a patient's response to treatment for an active M. tuberculosis infection. In a further embodiment, the present invention contemplates a method of monitoring a patient's response to treatment for an active M. tuberculosis infection.
    Type: Application
    Filed: February 11, 2013
    Publication date: August 14, 2014
    Inventors: Richard T. Robinson, Andrea M. Cooper
  • Patent number: 8394593
    Abstract: The present invention describes compositions for both diagnostic and therapeutic applications. In one embodiment, the present invention contemplates a vaccine formulation comprising an antigen and IL12R?1 isoform 2. In some embodiments, this invention relates to a method of quantifying the ratio of IL12R?1 transcript and a splice variant thereof in a sample, including but not limited to at the cDNA level. In other embodiments, this invention relates to a method of augmenting an immune response by administering, inhibiting and/or inducing IL12R?1 isoform 2.
    Type: Grant
    Filed: February 7, 2011
    Date of Patent: March 12, 2013
    Assignee: Trudeau Institute
    Inventors: Richard T. Robinson, Andrea M. Cooper
  • Publication number: 20110256158
    Abstract: The present invention describes compositions for both diagnostic and therapeutic applications. In one embodiment, the present invention contemplates a vaccine formulation comprising an antigen and IL12R?1 isoform 2. In some embodiments, this invention relates to a method of quantifying the ratio of IL12R?1 transcript and a splice variant thereof in a sample, including but not limited to at the cDNA level. In other embodiments, this invention relates to a method of augmenting an immune response by administering, inhibiting and/or inducing IL12R?1 isoform 2.
    Type: Application
    Filed: February 7, 2011
    Publication date: October 20, 2011
    Applicant: Trudeau Institute
    Inventors: Richard T. Robinson, Andrea M. Cooper
  • Patent number: 6097866
    Abstract: An optical fiber ribbon is disclosed. The optical fiber ribbon comprises a plurality of optical fibers arranged in a parallel planar array, the planar array being further defined by first and second planar sides spanning between first and second ends. A matrix material coating envelops the optical fibers so as to bond the optical fibers together in the parallel planar array. The matrix material coating forms a first substantially planar surface section spanning the first planar side of the planar array of optical fibers. A second substantially planar surface section spans the second planar side of the planar array of optical fibers. A first hinge section bridges the first and second substantially planar surface sections at the first end of the planar array and a second hinge section bridges the first and second substantially planar surface sections at the second end of the planar array.
    Type: Grant
    Filed: May 1, 1998
    Date of Patent: August 1, 2000
    Assignee: Alcatel
    Inventors: Houching M. Yang, Alfred L. Hinson, Richard T. Robinson
  • Patent number: 6066275
    Abstract: A method and apparatus for determining and controlling the excess length of a communications element disposed in a conduit is disclosed. The method includes the steps of measuring the length of a communications element being disposed within the conduit, placing a mark on the conduit each time a pre-determined length of the communications element is disposed within the conduit, and measuring the distance between the marks on the conduit. The excess length is determined by comparing the distance between the initial mark and the subsequent mark on the conduit to the measured length of the communications element disposed within the conduit. To control the excess length ratio, the conduit may be stretched, or process parameters related to formation of the conduit may be changed.
    Type: Grant
    Filed: July 7, 1998
    Date of Patent: May 23, 2000
    Assignee: Alcatel
    Inventors: Richard T. Robinson, James J. Puzan
  • Patent number: 4511278
    Abstract: A connector unit for connecting the struts of a geodesic dome framework is disclosed. The connector unit has the general shape of a frustum of a right circular cone. Five equally spaced rectangular depressions are formed in the upper surface of the frustum and a pair of flanges in mirror image relationship in planes perpendicular to the planes of the rectangular depressions are placed on opposite sides of each rectangular depression and each flange of the pair has an opening in its central area with the openings in register with each other.
    Type: Grant
    Filed: March 2, 1983
    Date of Patent: April 16, 1985
    Assignee: Delta Engineering Co.
    Inventor: Richard T. Robinson
  • Patent number: D259553
    Type: Grant
    Filed: June 22, 1978
    Date of Patent: June 16, 1981
    Assignee: August G. Carloni
    Inventor: Richard T. Robinson